The significance of preoperative atrial fibrillation in patients undergoing cardiac surgery: preoperative atrial fibrillation-still underestimated opponent

被引:48
作者
Banach, Maciej [1 ]
Mariscalco, Giovanni [2 ]
Ugurlucan, Murat [3 ]
Mikhailidis, Dimitri P. [4 ]
Barylski, Marcin [5 ]
Rysz, Jacek [5 ]
机构
[1] Med Univ Lodz, Dept Cardionephrol & Hypertens, PL-90549 Lodz, Poland
[2] Univ Insubria, Cardiac Surg Div, Dept Surg Sci, Varese, Italy
[3] Univ Rostock, Dept Cardiac Surg, Fac Med, Rostock, Germany
[4] UCL, Dept Clin Biochem, London, England
[5] Med Univ Lodz, Dept Nephrol Hypertens & Family Med, Lodz, Poland
来源
EUROPACE | 2008年 / 10卷 / 11期
关键词
Cardiac surgery; Complications; Preoperative atrial fibrillation; Predictors; Prognosis;
D O I
10.1093/europace/eun273
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atrial fibrillation (AF) has been described as an 'epidemic' due to its increasing prevalence in the ageing population. The prevalence of AF in the UK has risen from 0.78% in 1994 to 1.42% in 2006. The pathogenesis of AF seems to be multifactorial, and includes electrical and structural remodelling, and inflammation. As a result of recent developments in invasive cardiology together with improved pharmacological treatments, cardiac surgeons are increasingly operating on elderly patients with very advanced heart disease and other co-existent diseases. Therefore, AF is often present before cardiac surgery, increasing the risk of surgery and the occurrence of postoperative complications. According to available data, preoperative AF (pre-AF) should be considered as a high-risk marker of postoperative complications, which also significantly reduces long-term patient survival. However, although some multivariate models have concluded that pre-AF seems to be an independent predictor of outcome, this does not prove a cause-effect relationship. Therefore, such a link would need to be proven in prospective randomized studies, yet to be undertaken.
引用
收藏
页码:1266 / 1270
页数:5
相关论文
共 29 条
[1]   Relation between postoperative mortality and atrial fibrillation before surgical revascularization - 3-year follow-up [J].
Banach, M. ;
Goch, A. ;
Misztal, M. ;
Rysz, J. ;
Zaslonka, J. ;
Goch, J. H. ;
Jaszewski, R. .
THORACIC AND CARDIOVASCULAR SURGEON, 2008, 56 (01) :20-23
[2]   Risk factors of atrial fibrillation following coronary artery bypass grafting - A preliminary report [J].
Banach, M ;
Rysz, J ;
Drozdz, J ;
Okonski, P ;
Misztal, M ;
Barylski, M ;
Irzmanski, R ;
Zaslonka, J .
CIRCULATION JOURNAL, 2006, 70 (04) :438-441
[3]  
BANACH M, 2008, INTERACT CARDIOVASC, V7, pS49
[4]   Obesity and postoperative atrial fibrillation. is there no connection? Comment on: Wanahita et al. "Atrial fibrillation and obesity - results of a meta-analysis" [J].
Banach, Maciej ;
Goch, Jan Henryk ;
Ugurlucan, Murat ;
Rysz, Jacek ;
Mikhailidis, Dimitri P. .
AMERICAN HEART JOURNAL, 2008, 156 (01)
[5]   Statins in the prevention of postoperative atrial fibrillation: Is there really no effect? [J].
Banach, Maciej ;
Goch, Jan Henryk ;
Ugurlucan, Murat ;
Mariscalco, Giovanni ;
Rysz, Jacek .
AMERICAN HEART JOURNAL, 2008, 155 (06)
[6]   Letter by banach et al regarding article, "Postoperative treatment with carvedilol, a β-adrenergic blocker, prevents paroxysmal atrial fibrillation after coronary artery bypass grafting" [J].
Banach, Maciej ;
Mariscalco, Giovanni ;
Ugurlucan, Murat ;
Rysz, Jacek .
CIRCULATION JOURNAL, 2008, 72 (08) :1388-1388
[7]  
Banach M, 2008, MED SCI MONITOR, V14, pCR286
[8]  
Banach M, 2007, ARCH MED SCI, V3, P229
[9]  
Banach Maciej, 2005, Pol Merkur Lekarski, V19, P794
[10]  
Banach M, 2007, ARCH MED SCI, V3, P117